CoRPS Center of Research on Psychology in Somatic diseases The Medtronic Sprint Fidelis lead advisory notification has no adverse impact on patient reported.

Slides:

Advertisements

Similar presentations

EP Testing and Use of Devices in Heart Failure HFSA 2010 Recommendations.

Advertisements

Supported by grants from: National Human Genome Research Institute (ELSI) HG/AG (The REVEAL Study); National Institute on Aging AG (The MIRAGE.

Connie N. Hess, MD, Bimal R. Shah, MD, MBA, S. Andrew Peng, MS, Laine Thomas, PhD, Matthew T. Roe, MD, MHS, Eric D. Peterson, MD, MPH Relationship of Early.

Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)

Psychological Distress and Timely Use of Routine Care: The Importance of Having Health Insurance and a Usual Source of Care among Women with Children Whitney.

The Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision (CONNECT) Trial The Value of Remote Monitoring George H. Crossley, MD.

Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2014.

William H. Maisel, MD, MPH Director, Medical Device Safety Institute Beth Israel Deaconess Medical Center Statement to the FDA Risk Communication Advisory.

Visit our websites: PhD Study: Evaluation of the Efficacy of the Incredible.

Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2011.

Cohort Studies Hanna E. Bloomfield, MD, MPH Professor of Medicine Associate Chief of Staff, Research Minneapolis VA Medical Center.

報告者王瓊琦. postpartum depression : identification of women at risk.

Rivka Herman 1 *,RN. M.Sc Michal Libergal 1 *, PhD; David Rott 2, MD Michal Libergal 1 *, PhD; David Rott 2, MD 1 Henrietta Szold Hadassah-Hebrew University.

Cross-sectional cardiac rehabilitation with a Nurse Case Manager (GoHeart) improves risk factors, self-care and psychosocial outcomes. A 1-year follow-up.

TAVR Pearls Addressing the Shortcomings of the Current TAVR Generation

Quality of Life and Depression as Determinants of Treatment Adherence in Hypertensive Leonelo E. Bautista 1 ; Paul Smith 2 ; Cynthia Colombo 2 ; Dennis.

Frequency and type of adverse events associated with treating women with trauma in community substance abuse treatment programs T. KIlleen 1, C. Brown.

It’s Possible to prevent social exclusion among mentally ill?: IPSE Project, " Clinical Case Management " in Schizophrenic Patients in two catchment areas.

Renal function and clinical outcomes of patients undergoing ICD and CRTD implantation- Data from the Israeli ICD Registry Alon Eisen, Mahmoud Souleiman,

THE BODY PRO The HIV Resource for Health Care Professionals Copyright © 2009 The HealthCentral Network, Inc. All rights reserved. This activity is jointly.

May 2005 EP Show The EP Show COMPANION and CARE-HF Eric Prystowsky MD Director, Clinical Electrophysiology Laboratory St Vincent Hospital Indianapolis,

Author Disclosures Differences in Implantation-Related Adverse Events Between Men and Women Receiving ICD Therapy for Primary Prevention Differences in.

Self-reported cognitive and emotional effects and lifestyle changes shortly after preventive cardiovascular consultations in general practice Dea Kehler.

Feasibility and validity of four patient reported outcome measures in the Danish Hip Arthroplasty Registry Aksel Paulsen, M.D., Ph.D. Fellow Department.

Procedural Interventions And Chronic Low Back Pain: Changes Over One Year This sample included 137 patients with complete surveys and chart reviews; 74%

Psychosocial consequences of false- positive screening results - breast cancer as an example John Brodersen MD, GP, PhD The Department of General Practice.

EP Show – Aug 2003 ICDs – Secondary prevention The EP Show: Which ICD for which patient? Part 1: Secondary prevention Eric Prystowsky MD Director, Clinical.

® Introduction Changes in Opioid Use for Chronic Low Back Pain: One-Year Followup Roy X. Luo, Tamara Armstrong, PsyD, Sandra K. Burge, PhD The University.

New Technologies & Challenges in optimizing the “heart health” of Australia Professor Simon Stewart Head, Preventative Cardiology

Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2- Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic.

Adverse Outcomes After Hospitalization and Delirium in Persons with Alzheimer Disease Charles Wang, PharmD Candidate.

Teaching of psychosocial issues in occupational medicine and case management FROM THE NORWEGIAN PERSPECTIVE EASOM Summer school 2015 Lake Bled Kristin.

Predictors of Asthma in Young Children Does Reporting Source Affect Our Conclusions? Jane E. Miller Jane E. Miller, Ph.D. Institute for Health, Health.

Quality of life in patients with implantable cardioverter defibrillators Author: Camelia Tănăsuc Coordinator: Professor Doctor Dan Dobreanu Coauthors:

Do veterans with spinal cord injury and diabetes have greater risk of macrovascular complications? Ranjana Banerjea, PhD 1, Usha Sambamoorthi, PhD 1,2,3,

Prenatal and Early Life Factors that Predict Risk for Developmental Problems: A Longitudinal Cohort Study Suzanne Tough PhD 1,2, Jodi Siever MSc 3, Karen.

EP show – June 2004 EP show The EP show: Risk stratification for sudden death Eric Prystowsky MD Director, Clinical Electrophysiology Laboratory St Vincent.

Janet Lin, MD, MPH, Sweta Basnet, MS, Sara Baghikar, MD, Cammeo Mauntel-Medici, MPH, Sara Heinert, MPH University of Illinois at Chicago, College of Medicine,

Lessons Learned in Geriatric Collaborative Care: What if the Status Quo Just Won’t Budge? Katherine Buck, MS, LMFT Psychology Intern, University of Colorado.

Use of lung function tests in paediatric asthma care A nationwide registry study Grete Moth, MHSc, Ph.D Danish Paediatric Asthma Centre Aarhus University.

Antiplatelet Therapy Use after Discharge among Acute Myocardial Infarction Patients with In-hospital Bleeding Tracy Y. Wang, MD, MHS, Lan Xiao, PhD, Karen.

COPE: Community Parent Education Program Evidence Base and Future Directions Charles E. Cunningham, Ph.D. Professor Department of Psychiatry & Behavioural.

PHQ-9 Severity and Screening Tests Predictive of Remission Outcomes at Six Months Kurt B. Angstman, MS MD Associate Professor John M. Wilkinson Assistant.

CoRPS Center of Research on Psychology in Somatic diseases Depression and anxiety in atrial fibrillation patients - is this undertreated? Susanne S. Pedersen,

CoRPS Center of Research on Psychology in Somatic diseases Quality of life. How to evaluate? Susanne S. Pedersen, Professor of Cardiac Psychology.

CoRPS Center of Research on Psychology in Somatic diseases Cardiac Psychology: A match made in heaven for patients Susanne S. Pedersen, Professor of Cardiac.

CoRPS Center of Research on Psychology in Somatic diseases E-health for implantable cardioverter defibrillator patients to improve secondary prevention:

CoRPS Center of Research on Psychology in Somatic diseases Positive and negative emotions and heart disease Susanne S. Pedersen, Professor of Cardiac Psychology.

CoRPS Center of Research on Psychology in Somatic diseases Psychosocial support Susanne S. Pedersen, Professor of Cardiac Psychology.

CoRPS Center of Research on Psychology in Somatic diseases Patients with an ICD Susanne S. Pedersen, Professor of Cardiac Psychology.

CoRPS Center of Research on Psychology in Somatic diseases Type D personality as a risk factor for adverse vascular outcomes in diabetes patients: A role.

Increased Patient Device Concerns But Not General Anxiety in Patients with a Secondary Indication for the ICD Susanne S. Pedersen, Professor of Cardiac.

CoRPS Center of Research on Psychology in Somatic diseases Poor health status in implantable cardioverter defibrillator patients: Shock, patient pre implantation.

CoRPS Center of Research on Psychology in Somatic diseases Tilburg University The Netherlands Predictors of posttraumatic stress (PTSD) 18 months post.

Tobacco treatment TrAining Network in Crete Tobacco treatment TrAining Network in Crete.

Date of download: 6/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Implantable Cardioverter Defibrillators and Quality.

CoRPS Center of Research on Psychology in Somatic diseases The patient perspective on LVAD implantation – a neglected dimension? Prof. dr. Susanne S. Pedersen,

CoRPS Disclosures None. CoRPS Center of Research on Psychology in Somatic diseases Impact of psychological profile in heart failure patients Susanne S.

CoRPS Center of Research on Psychology in Somatic diseases Inflammation, Mediation and Type D personality Multiple inflammatory biomarkers as mediators.

Correlates of Patient Acceptance of the Cardioverter-Defibrillator: Cross-validation of the Florida Patient Acceptance Survey in Danish Patients Correlates.

Date of download: 6/26/2016 From: Cost-Effectiveness of Adding Cardiac Resynchronization Therapy to an Implantable Cardioverter- Defibrillator Among Patients.

CoRPS London 26 & 27 October 2010 Center of Research on Psychology in Somatic diseases Understanding PRO in hematological disorders: Do we have a consensus?

CoRPS Center of Research on Psychology in Somatic diseases Brief Depression Screening with the PHQ-2 Predicts Poor Prognosis following PCI with Drug-Eluting.

CoRPS Center of Research on Psychology in Somatic diseases Depression is associated with a 2-fold independent risk of mortality in implantable cardioverter.

CoRPS Center of Research on Psychology in Somatic diseases ICD patients with anxiety: what to do? Susanne S. Pedersen, Professor of Cardiac Psychology.

Author Disclosure Sex Differences in the Characteristics of Patients Receiving ICD Therapy for the Primary Prevention of Sudden Cardiac Death –Stacie L.

How Patients Discuss Their Risk: Words and Numbers

Dr. Muhammad Ajmal Zahid Chairman, Department of Psychiatry,

Antiplatelet Therapy Use after Discharge among Acute Myocardial Infarction Patients with In-hospital Bleeding Tracy Y. Wang, MD, MHS, Lan Xiao, PhD, Karen.

Transcatheter versus medical treatment of symptomatic severe tricuspid regurgitation: a propensity score matched analysis Maurizio Taramasso MD, PhD from.

Presentation transcript:

CoRPS Center of Research on Psychology in Somatic diseases The Medtronic Sprint Fidelis lead advisory notification has no adverse impact on patient reported outcomes in Danish implantable cardioverter defibrillator patients Susanne S Pedersen (PhD) 1,2,3 Professor of Cardiac Psychology 1 CoRPS - Center of Research on Psychology in Somatic diseases, Tilburg University, The Netherlands 2 Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands 3 Department of Cardiology, Odense University Hospital, Denmark 4 Department of Cardiology, Aarhus University Hospital, Denmark Co-authors: Henneke Versteeg (MSc) 1 Jens Cosedis Nielsen (MD, PhD) 4 Peter T Mortensen (MD) 4 Jens Brock Johansen (MD, PhD) 3

CoRPS Disclosures Moderate speaker or consultancy fee from: Medtronic St. Jude Medical Cameron Health Sanofi Aventis

CoRPS Background: General Urgent need to examine the influence of advisory notifications on patient well being and how to communicate the risk to patients A true estimation of the impact of advisories on patients may counterbalance the associated negative publicity in the press Cannom & Fisher. Pacing Clin Electrophysiol 2008; 31:1233-5

CoRPS Negative publicity has consequences Dr. Christopher J. Magovern, right, at Morristown Memorial Hospital in New Jersey during a procedure Tuesday to replace a patient’s defibrillator and the wire that connects it to the heart. Feder. New York Times, December 13, 2007 Feder, New York Times, September 12, 2008 But thousands of other patients with failing hearts remain trapped in doubt…. Should they have the potentially faulty wire, or lead, removed - or leave it in place and hope it does not fail? Dr. Eric N. Prystowsky, a nationally renowned heart rhythm specialist in Indianapolis, said every doctor in his field was haunted by individual cases… The student had an abnormally thick heart muscle, a known risk for sudden cardiac arrest. “He kept putting it off,” Dr. Prystowsky said of the decision to get a defibrillator. “Six weeks later, his fiancée called to say he had been found dead in bed.”

CoRPS Background: Studies to date 273 advisory patients

CoRPS Objectives 1.To examine whether the mode used to inform patients about the Sprint Fidelis device advisory is associated with patient reported outcomes (PROs) 2.To determine whether patients with a device advisory notification report poorer PROs compared to non advisory patients

CoRPS Methods: Study design and participants Case-control study Cases: 207 patients implanted with an ICD between at Aarhus University Hospital (Skejby), Denmark, and with a lead (6931 or 6949) subject to the Medtronic Sprint Fidelis ICD lead advisory  (response rate 87%) Controls*: 510 patients implanted with an ICD between without hardware subject to advisory  (response rate 84%) * Johansen, Pedersen et al. Europace 2008;10:545-51

CoRPS Methods: Mode of informing patients (i)By letter in December of 2008 calling them in for an urgent clinical follow-up visit (ii)Informing them ad-hoc during a routine clinical visit * Both groups had the Lead Integrity Alert (LIA) software downloaded to their device and were informed about the rationale at the time of downloading it to their device. The interval between the device advisory notification and completing the questionnaires was 9 months in group (i), while for group (ii) the interval was variable

CoRPS Methods: Patient reported outcomes (PROs) Anxiety and depression: Hospital Anxiety and Depression Scale (HADS) Device concerns: ICD Patient Concerns Questionnaire (ICDC) * Device acceptance: Florida Patient Acceptance Survey (FPAS) * Health status: Minnesota Living with Heart Failure Questionnaire (MLHFQ) * Short Form Health Survey (SF-36) * Disease-specific measure

CoRPS Results: Baseline characteristics stratified by device advisory mode and controls CharacteristicsDevice advisory (i) (N = 74) Device advisory (ii) (N = 133) Controls (N = 510)p Demographic Women8 (10.8)20 (15.0)92 (18.0).26 Age, mean ±SD63.2 ± ± ± Partner/married58 (78.4)102 (77.1)393 (77.5).94 Clinical CRT-D22 (30.1)30 (22.6)92 (18.0).04 Comorbidity15 (20.8)29 (22.3)116 (23.0).92 Ischemic heart disease49 (70.0)81 (67.5)327 (70.6).80 Smoking13 (17.6)26 (19.8)119 (23.8).36 Time since first ICD implant (yrs)2.0 ± ± ±3.2< Medication Amiodarone10 (15.4)34 (27.0)123 (24.4).19 Beta-blockers54 (83.1)116 (92.1)412 (82.4).03 Diuretics28 (43.1)54 (42.9)236 (46.9).64 Thiazide diuretics10 (15.4)12 (9.5)46 (9.3).30 ACE-inhibitors52 (80.0)98 (77.8)345 (69.8).07 ARBs13 (20.0)37 (29.4)156 (31.1).18 Digoxin15 (23.1)23 (18.3)84 (16.7).43 Psychotropic medication11 (16.9)9 (7.2)67 (14.1).08

CoRPS Results: Psychological distress stratified by device advisory notification mode

CoRPS Results: Health status stratified by device advisory notification mode

CoRPS Results: Psychological distress stratified by device advisory status Controls more ICD concerns

CoRPS Results: Health stratified by device advisory status Controls poorer Mental Health

CoRPS Strengths Second largest cohort of device advisory patients to date First Danish study Use of a wide range of PROs (i.e., distress, device acceptance, and health status) Use of both disease-specific and generic PROs Keren, Sears et al. J Cardiovasc Electrophysiol 2011;22:57-63

CoRPS Limitations Convenience sample as control group Time interval (>9 months) from notification to patient completion of PROs – patients may adapt over time No evaluation of patient perception of the risk of having a recalled Sprint Fidelis lead Control cohort was predominantly secondary prevention

CoRPS Conclusions Mode used to inform ICD patients about the Sprint Fidelis lead advisory was not associated with PROs Device advisory patients reported similar well being and health status as compared to controls Results indicate that ICD patients are generally able to cope with a device advisory Lead failures are likely to be here to stay - suggestion to include routine and serial assessments of PROs in national registries Pedersen, Theuns, et al. Pacing Clin Electrophysiol 2009;32:

CoRPS Living in a Device World: Focus on Recent Challenges and Tools to Improve Clinical Care for Patients with an Implantable Cardioverter Defibrillator Device Conference, 3-4 November 2011, Tilburg, the Netherlands Themes OVERCOMING THE SHOCK OF THE ICD ICD REGISTRIES AND THE INCLUSION OF THE PATIENT PERSPECTIVE DEACTIVATION OF THE ICD AND END OF LIFE ISSUES NEGLECTED SUBGROUPS CRT SELECTION AND RESPONSE THE DO’S AND DON’TS OF PATIENT COMMUNICATION SEXUALITY IN ICD PATIENTS BEHAVIORAL INTERVENTIONS LOOKING INTO THE FUTURE Selection of invited faculty Nico Blom (MD, PhD), Leiden University Medical Center, NL Matthew Burg (PhD), Yale School of Medicine, USA Viviane Conraads (MD, PhD), University Hospital Antwerpen, BE Dorothy Frizelle (PhD), University of Hull, UK Jens Brock Johansen, (MD, PhD), Odense University Hospital, DK Karl-Heinz Ladwig (MD, PhD), Helmholtz Institute, Munich, GE Mathias Meine (MD, PhD), University Medical Center Utrecht, NL Susanne S. Pedersen (PhD), CoRPS, Tilburg University, NL Samuel Sears (PhD), East Carolina University, USA Steen Pehrson (MD, PhD), Copenhagen University Hospital, DK Dominic Theuns (PhD), Erasmus Medical Center Rotterdam, NL More information available on: